Introduction
Allergic conjunctivitis encompasses a variety of ocular inflammatory diseases that are elicited by immediate hypersensitivity responses to environmental agents. Studies [1, 2] have reported that between 20 and 30% of the population in industrialized countries such as the United States have experienced allergies, with 50% of these individuals reporting ocular allergies. The incidence of allergies, including allergic conjunctivitis, has increased steadily over the past 30 years. Allergic conjunctivitis can occur as a mild, transient inflammation, such as seasonal allergic conjunctivitis or as more severe chronic forms such as atopic keratoconjunctivitis (AKC) or vernal keratoconjunctivitis (VKC). Allergic conjunctivitis is initiated by the preferential activation and polarization of the immune response to environmental agents that culminates in the generation of a Th2-dominated immune response and the preferential generation of IgE antibodies.
The early phase of allergic conjunctivitis occurs when allergens at the ocular surface engage their specific IgE antibodies that are bound to FceRI receptors on conjunctival mast cells. The cross-linking of IgE antibodies triggers the degranulation of mast cells resulting in the release of a variety of mediators, including vasoactive amines such as histamine. This early phase response is characterized by vasodilatation, increased vasopermeability, and itching. The early phase reaction (EPR) is followed by a late phase reaction (LPR) that begins 6-12 h later and involves the infiltration of inflammatory cells, especially eosinophils. Antigen-specific T cells initiate eosinophil infiltration into the conjunctiva, which can result in tissue damage [3] . Severe allergic inflammation of the conjunctiva is mediated primarily by infiltrating eosinophils.
The past 2-3 years have witnessed significant new perspectives regarding the regulatory pathways that influence
Purpose of review
This review highlights recent findings regarding the immune regulation of allergic conjunctivitis. Mouse models have facilitated prospective studies that have not been possible in patients. The availability of gene knockout mice and the wealth of monoclonal antibodies have permitted exquisite dissection of the pathophysiology and immune regulation of allergic conjunctivitis.
Recent findings
New insights have emerged in three areas: role of costimulatory molecules in the induction of Th2 immune responses; crucial role of IFN-g in the expression of allergic conjunctivitis; and the function of T regulatory cells in shaping conjunctival inflammation once the immune response has been initiated. Summary Allergic conjunctivitis involves early phase and late phase reactions. The early phase reaction is IgE antibody-dependent, whereas the late phase reaction is IgEindependent and is mediated by inflammatory cells, especially eosinophils. Recent studies on mouse models of allergic conjunctivitis have provided important insights into the immune regulation of both the early phase reaction and late phase reaction of allergic conjunctivitis. Mounting evidence suggests that IFN-g is crucial for optimum expression of allergic conjunctivitis. Costimulatory molecules influence the induction of Th2 immune responses and the early phase reaction, whereas regulatory T cells shape the expression of the late phase reaction of allergic conjunctivitis. the early and late phases of allergic conjunctivitis. These insights are largely the result of prospective studies on mouse models of allergic conjunctivitis.
The late phase response is sustained by T cell-dependent processes Allergic conjunctivitis, like other allergic diseases, is initiated when the offending allergen cross links allergen-specific IgE that is bound to Fc receptors on mast cells. The ensuing activation and degranulation of mast cells culminates in the release of amines that produce the vascular changes characteristic of the EPR. However, mast cell activation also results in the release of proinflammatory molecules such as eosinophil chemotactic factor (ECF) and platelet-activating factor (PAF), which recruit and activate eosinophils. Thus, the segue from EPR to LPR requires mast cell activation and degranulation. However, studies on murine models of allergic conjunctivitis [4, 5] suggest that once initiated, the LPR can proceed in the presence of little or no detectable allergen-specific IgE antibody. Passive transfer of IgE antibodies specific for short ragweed pollen (SRW) produces only mild LPR in mice challenged topically with SRW pollen [5] . Moreover, in an ovalbumin (OVA) model of allergic conjunctivitis, the LPR occurs in the absence of detectable anti-OVA IgE [4] . Importantly, LPR can readily be induced by adoptively transferring T cells from allergen-sensitized donors to naïve recipients prior to challenging the ocular surface with the relevant allergens [4, 5] . Interestingly, in mouse models of allergic conjunctivitis, adoptively transferred T cells produce significant quantities of IFN-g in addition to Th2 cytokines. These results are consistent with a recent study, which showed that SRW-induced allergic conjunctivitis was milder in IFN-g knockout mice or wildtype mice treated with anti-IFN-g antibody [6] . A recent study on allergic conjunctivitis and VKC patients lends further support to the notion that the Th1 cytokine, IFN-g, contributes to the pathogenesis of allergic conjunctivitis. Leonardi et al. [7] examined cytokine levels in tear samples collected from AKC and VKC patients and found that IFN-g was the dominant cytokine in as many as 25% of the VKC patients. Moreover, IFN-g was present in the tears of over 80% of the VKC patients and over 40% of the AKC patients. The inferred role of IFN-g in allergic conjunctivitis and VKC is counterintuitive when one considers the widely recognized capacity of this cytokine to cross-regulate the generation of Th2 cytokines. However, the production of IFN-g in patients with AKC and VKC and in mice with experimental allergic conjunctivitis begs the question as to how IFN-g might contribute to conjunctival inflammation. Recent studies using the SRW model of allergic conjunctivitis have shed light on this. IFN-g knockout mice and wild-type mice treated with anti-IFN-g antibody displayed milder allergic conjunctivitis than wild-type mice [6] . Interestingly, mice deficient in IFN-g failed to express vascular cell adhesion molecule-1 (VCAM-1) on their conjunctival blood vessels. VCAM-1 is an important cell adhesion molecule that is a coligand for very late antigen-4 (VLA-4), which is expressed on eosinophils and facilitates their emigration into inflammatory sites [8] [9] [10] . If IFN-g facilitates the full expression of the LPR in allergic conjunctivitis by promoting VCAM-1 expression, it should be possible to mitigate allergic conjunctivitis by blocking VLA-4/VCAM-1 interactions. This in fact occurred when SRW-sensitized mice were treated with anti-VLA-4 or anti-VCAM-1 antibody prior to ocular challenge with SRW pollen [11] . These results remind us of the pleiotropic nature of IFN-g and demonstrate its capacity to influence the end stages of both Th1-based and Th2-based inflammation.
Costimulatory molecular interactions affect the induction of Th2 immunity and the late phase response in allergic conjunctivitis
The activation and expansion of naïve T cells requires the delivery of two signals. The first signal is transmitted to the T cell receptor by cognate antigen presented on major histocompatibility complex (MHC) molecules on antigen presenting cells (APC). The second signal is provided by interaction between costimulatory molecules expressed on APC and their ligands on T cells.
Members of the CD28 family of costimulatory molecules include B7-1 and B7-2, which are widely recognized as key costimulatory molecules for T cell activation. Recent studies using SRW pollen model of allergic conjunctivitis demonstrated the blockade of the B7-1 and B7-2 costimulatory molecules on APC at the time of initial sensitization to SRW pollen resulting in reduced T cell production of IL-5, a key Th2 cytokine necessary for eosinophil recruitment to the conjunctiva [12 ] . This in turn was associated with a significant reduction in eosinophil inflammation of the conjunctiva.
In addition to the CD28 family of costimulatory molecules, members of the tumor necrosis factor (TNF) receptor family also contribute to T cell activation [13] . OX40 (CD134) is a member of the TNF receptor family that is expressed on CD4 þ T cells and has been shown to facilitate the generation of Th2 cells [14, 15] . In vivo studies [16] using the SRW model of allergic conjunctivitis demonstrated that OX40/OX40L interactions were critical for the induction of Th2 immune responses and the clinical manifestations of allergic conjunctivitis; that is, mice treated with an agonistic OX40 antibody developed more severe clinical symptoms of allergic conjunctivitis and displayed more intense eosinophil inflammation in the conjunctiva compared with control mice. Splenocytes from mice treated with agonistic anti-OX40 produced increased quantities of IL-5 and less IFN-g. In a similar vein, treatment with a blocking antibody to OX40L resulted in milder allergic conjunctivitis, decreased production of IL-5, and elevated IFN-g. B7-H3 is another costimulatory molecule that is expressed on T cells and has been shown to provide a positive signal for Th1 cell development [17] . Studies [18 ] using the same mouse model of SRW-induced allergic conjunctivitis demonstrated that T cells from mice treated with anti-B7-H3 antibody produced significantly higher levels of IL-5 and IL-13. Moreover, anti-B7-H3-treated mice also displayed more intense eosinophil infiltration of the conjunctiva. Thus, blocking the B7-H3 costimulatory molecule blunts Th1 immune responses and presumably releases Th2 responses from Th1 cross-regulation, thereby resulting in an exacerbation of allergic conjunctivitis.
Do regulatory T cells shape the expression of allergic conjunctivitis?
Regulatory T cells (T regs ) influence the expression of immune-mediated inflammation of the ocular surface and the survival of corneal allografts [19] [20] [21] [22] [23] . Recent studies on mouse models of allergic conjunctivitis suggest that T regs also influence the LPR of allergic conjunctivitis. Natural killer T (NKT) cells are a heterogeneous population of lymphocytes that coexpress the T cell receptor (TCR) and NK markers and have the capacity to act as 'first responders' in the immune surveillance of malignancies and microbial infections [24] [25] [26] . NKT cells also display immunoregulatory properties and are crucial for the induction of some forms of immune tolerance [27] . The synthetic glycolipid, a-galactosylceramide (a-GalCer), stimulates NKT cells to express immunoregulatory functions and has been used to mitigate experimental autoimmune diseases [28] . With this in mind, Fukushima et al. [29] tested the effect of a-GalCer on SRW-induced allergic conjunctivitis in mice. Their findings revealed that treatment with a-GalCer at the time of ocular challenge with SRW pollen resulted in a significant mitigation in allergic conjunctivitis that coincided with a ten-fold increase in the expression of Foxp3 in CD4 þ CD25 þ T cells; that is, a steep increase in putative T regs . The a-GalCer-induced attenuation of allergic conjunctivitis was most likely due to the generation of CD4
þ T regs and not a result of cross-regulation of Th2 cells by IFN-g, as a similar effect was found in IFN-g knockout mice. One of the mechanisms utilized by CD4
þ CD25 þ Foxp3 þ T regs is through their production of anti-inflammatory cytokines, transforming growth factor-b (TGF-b), and IL-10. It is noteworthy that in addition to its anti-inflammatory properties, IL-10 has recently been shown to stabilize mast cells and reduce their degranulation in vitro and as a result attenuate allergic conjunctivitis in a mouse model of allergic conjunctivitis [30 ] .
The hygiene hypothesis and allergic conjunctivitis
The past 30 years have witnessed a steep increase in the incidence of allergic diseases. Although many explanations have been offered to account for this, none has captured more attention and provoked more discussion than the 'hygiene hypothesis', which was formulated by Strachan [31] almost 20 years ago. In its simplest form, the hygiene hypothesis proposes that reduced exposure to infections in early childhood reduces the incidence of allergic diseases by some unknown mechanism. The emergence of Th1 and Th2 cell paradigm in the 1980s provided a simple mechanistic explanation for the increased incidence of allergic disease in industrialized societies that were noted for their high standards of hygiene. In such societies, antibiotic use is widespread in patients and even in livestock and poultry. This results in reduced exposure to microbial infections. By contrast, in developing countries, microbial infections are more commonplace and trigger Th1 responses that are characterized by the elaboration of IFN-g, which is known to downregulate the emergence of Th2 cells and the production of Th2 cytokines. Thus, frequent microbial infections might create a persistent cytokine milieu that discourages the generation of Th2 immune responses, resulting in milder or less frequent atopic diseases. However, this explanation has fallen to the wayside with numerous observations indicating that helminth infections, which are notorious for provoking robust Th2 immune responses, were associated with a steep reduction in allergic diseases [32] [33] [34] . Moreover, the incidence of Th1-mediated autoimmune diseases is significantly lower in undeveloped countries and the severity of experimental autoimmune diseases is remarkably milder in animals bearing helminth infections [34] . A number of appealing propositions have been offered to explain the hygiene hypothesis. Among these is the notion that microbial infections, especially parasitic infections, induce the generation of T regs that dampen both Th1 and Th2 immune responses, and thus, reduce the incidence and severity of allergic diseases and autoimmune diseases.
Studies on the SRW model of allergic conjunctivitis suggest that the hygiene hypothesis applies to allergic conjunctivitis. Chronic infection with the nematode, Ascaris suum, resulted in a global increase in IL-10 and an attenuation of SRW pollen-induced allergic conjunctivitis [35] . Adoptive transfer of CD4 þ CD35 þ T cells from A. suum-infected mice to recipient mice sensitized with SRW pollen and challenged topically with SRW allergens resulted in significant mitigation of allergic conjunctivitis. Follow-up studies [36] found that infection with viable A. suum was not necessary for mitigating allergic conjunctivitis and simply injecting pseudocoelomic fluid from A. suum into mice at the time of SRW sensitization protected against allergic conjunctivitis. However, protection was IL-10-indendent, as mitigation of allergic conjunctivitis was detected in IL-10 knockout mice. The authors suggested that A. suum pseudocoelomic fluid modulated allergic conjunctivitis by downregulating costimulatory molecule (CD86) expression on APC. Thus, the immunomodulatory effects of helminth and microbial infections may involve multiple pathways and are most likely not restricted to a single mechanism such as the generation of CD4 þ
CD25
þ Foxp3 þ T regs . Whatever the mechanisms turn out to be, it is clear that we are at an exciting juncture in understanding the immune regulation of allergic conjunctivitis and the influence of infectious, and perhaps noninfectious, environmental agents in this process. Unfolding the mysteries of the hygiene hypothesis may yield important new strategies for treating the everexpanding population of individuals who suffer from allergic diseases.
Conclusion
Animal models have provided enormous insights into the pathophysiology and immunobiology of allergic eye diseases. In the past 2-3 years, these studies have demonstrated the role of costimulatory molecules, cytokines, chemokines, and T regs in both the early and late phases of allergic conjunctivitis. These investigations offer hints for novel therapeutic interventions that can be tailored to treat individual stages of the allergic conjunctivitis cascade. The hygiene hypothesis has provided a fresh and novel perspective for understanding the epidemiology of allergic eye diseases and offers glimpses of novel therapies that can target each phase of ocular inflammation. The next 2-3 years will undoubtedly yield even more intriguing insights into the pathology, immunobiology, and epidemiology of allergic eye disease.
